There were two successful days for Firalis and its associates Florian Still and Xavier Preville at the 12th Annual Biomarkers Congress in Manchester. Countless interested visitors met at the company's booth in order to discuss about biomarker discovery and Xavier Preville was honored to chair Charter 1 / Stream 1 in the congress on the…Read more
Duis ultrices purus tortor! Maecenas semper magna at risus rhoncus euismod. Fusce fringilla, quam et dictum vestibulum, nunc sapien imperdiet odio, et convallis lorem augue vitae sem. Vestibulum mattis orci a est bibendum mollis. Ut varius felis nec lectus tinci auctor quam hendrerit odio placerat tempor. Phasellus diam quam, auctor vel blandit vel; tristique id lectus. Nam consequat leo hendrerit mi posuere nec vulputate mauris sagittis. Aenean porttitor metus vitae dui fermentum posuere.
Recent Posts by admin
Firalis, designated as “Certified by Olink”, has successfully completed the Proseek® Multiplex Analysis Certification process, with hands-on instructions and an evaluation by the Olink Analysis Service team. Explore with us the new Olink technology: the high-throughput Proseek® Multiplex immunoassays. Firalis can support you in providing new insights into protein biomarker discovery, with attention to disease…Read more
Firalis, lauréat du prix Deloitte In Extenso Technology Fast 50 2016 Huningue, France, 10 février 2017 Firalis annonce aujourd’hui qu’elle a obtenu le 6e prix du Deloitte In Extenso Technology Fast 50 qui récompense les entreprises technologiques à forte croissance. Ce palmarès est réalisé en fonction du taux de croissance du…Read more
At the EUROTOX 2009 conference in Dresden, the SAFE-T Project has been launched by Prof. Hüseyin FIRAT (President of Firalis) and it has recently achieved a major step. The Innovative Medicines Initiative (IMI) SAFE-T (Safer and Faster Evidence Based Translation) Consortium and The Critical Path Institute (C-Path) have announced on 17th October 2016 that both,…Read more
Recent Comments by admin
No comments by admin yet.